Found 3,739 clinical trials

J JANE ANDERSON

Test Trial API-01 trial & test1234

See protocol section 2 See protocol section 2 See protocol & section 2

99 years and younger All Phase N/A

UPENN Case Test Trial 2 (Do Not Make Any Changes)

100 years and younger All Phase N/A

U Upenn Site User 5

UPENN Case Test Trial 5 (Do Not Make Any Changes)

100 years and younger All Phase 2

U Upenn Site User 9

UPENN Case Test Trial 7 (Do Not Make Any Changes)

100 years and younger All Phase N/A

U Upenn Site User 6

UPENN Case Test Trial 8 (Do Not Make Any Changes)

100 years and younger All Phase N/A

U Upenn Site User 11

UPENN Case Test Trial 12 (Do Not Make Any Changes)

100 years and younger All Phase N/A

E Eileen Chang, BA, CCRP

Diffusion MRI for Head and Neck Cancer

The proposed study is to investigate the feasibility of using quantitative diffusion MRI (dMRI) methods for accurate and comprehensive assessment of treatment response. dMRI is a powerful tool to probe treatment-induced change in tumors. It is a unique in vivo imaging technique sensitive to cellular microstructures at the scale of …

18 years and older All Phase N/A

Z Ze-Rui Zhao

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

The goal of this clinical trial is to evaluate the clinical value of ctDNA testing in guiding the optimization of immunochemotherapy cycles during induction treatment for resectable patients with NSCLC. The main questions it aims to answer are:Does ctDNA clearance indicate pathological complete response?Are additional cycles of immunochemotherapy necessary for …

18-75 years All Phase 2

N Nicholas Guenzel, PhD

Group Activities to Support Addiction Recovery

The purpose of this study is to pilot the use of Holotropic Breathwork (HB) for individuals seeking to recover from addiction. The study will have two arms: A--for individuals in residential treatment programs, B--for individuals living in the community. Arm A will use a cluster randomized intervention, providing HB for …

19 years and older All Phase N/A

W Wei Hu, Ph.D

A Phase I Study of SNH-119014 in Healthy Volunteers

SNH-119014 is an oral small-molecule agonist of pyruvate kinase red blood cell isozyme (PKR) being developed for the treatment of hemolytic anemias. This initial study will characterize the safety, tolerability and the pharmacokinetics/pharmacodynamics (PK/PD) of a single ascending dose and multiple ascending doses of SNH-119014 in the context of Phase …

18-45 years All Phase 1